Acetylcholinesterase inhibitors in the context of therapeutic strategies to combat Alzheimer’s disease

Author： Recanatini Maurizio   Cavalli Andrea  

Publisher： Informa Healthcare

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.12, Iss.12, 2002-12, pp. : 1853-1865

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Acetylcholinesterase inhibitors in the treatment of Alzheimer’s disease

By Gauthier S.  

Expert Opinion on Investigational Drugs, Vol. 8, Iss. 10, 1999-10 ,pp. : 1511-1520

Informa Healthcare

Access to resources Recommend Favorite

Intranasal therapeutic strategies for management of Alzheimer’s disease

By Sood Sumeet   Jain Kunal   Gowthamarajan K.  

Journal of Drug Targeting, Vol. 22, Iss. 4, 2014-05 ,pp. : 279-294

Informa Healthcare

Access to resources Recommend Favorite

QSAR Applications During Last Decade on Inhibitors of Acetylcholinesterase in Alzheimer's Disease

By  

Mini Reviews in Medicinal Chemistry, Vol. 12, Iss. 10, 2012-09 ,pp. : 936-946

Bentham Science Publishers

Access to resources Recommend Favorite

Development of Bivalent Acetylcholinesterase Inhibitors as Potential Therapeutic Drugs for Alzheimer's Disease

By  

Current Pharmaceutical Design, Vol. 10, Iss. 25, 2004-10 ,pp. : 3141-3156

Bentham Science Publishers

Access to resources Recommend Favorite

Cyclo-Oxygenase-2 Inhibitors: Rationale and Therapeutic Potential for Alzheimer’s Disease

By McGeer P.L.  

Drugs & Aging, Vol. 17, Iss. 1, 2000-07 ,pp. : 1-11

Adis International

Access to resources Recommend Favorite